Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/08/21 Updated
Market Cap: $32.8B (¥5.2T)
Stock Price: $18.04 (¥2,868)
Exchange Rate: 1 USD = ¥158.98

Financial Guidance Revision Announcement for FY2025

For FY2025, net sales are revised to JPY 2,123 billion (up JPY 23 billion from the previous forecast), core operating profit is revised to JPY 360 billion (+JPY 10 billion), and operating profit is revised to JPY 229 billion (down JPY 106 billion).

Importance:
Page Updated: May 8, 2026
IR Disclosure Date: May 8, 2026

Key Figures

  • Net Sales: JPY 2,123 billion (up JPY 23 billion from previous estimate)
  • Core Operating Profit: JPY 360 billion (up JPY 10 billion from previous estimate)
  • Operating Profit: JPY 229 billion (down JPY 106 billion from previous estimate)

AI要約

Overview of Earnings Guidance Revision

Daiichi Sankyo Company Limited has revised its consolidated earnings forecast for FY2025, increasing net sales to JPY 2,123 billion (up JPY 23 billion from the previous forecast) and core operating profit to JPY 360 billion (up JPY 10 billion). However, operating profit is expected to decline to JPY 229 billion (down JPY 106 billion), mainly due to loss compensation provisions for CMO-related costs, impairment losses on equipment at Odawara Plant ADC, and an increase in one-off expenses such as compensation payments. Pre-tax profit is projected at JPY 264 billion (down JPY 91 billion), and net income attributable to owners of the parent is forecasted at JPY 260 billion (down JPY 28 billion).

Manufacturing & Supply Strategy and Dividend Policy

Under the ADC manufacturing and supply strategy, the company is progressing with outsourcing manufacturing to CMO and investing in its own manufacturing facilities to expand production capacity step by step. It is also strengthening global supply chain optimization and BCP measures to establish a stable supply system. Regarding dividend policy, the estimated annual dividend for FY2025 remains unchanged at JPY 78 per share, with a continued trend of dividend increases from FY2026 onward.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Company Limited

Company overview · Stock price · Financial data · All IR

View company page →